How coffee affects the risk of developing Parkinson's disease - study

Swedish scientists have found that regular coffee consumption may reduce the risk of developing Parkinson's and Alzheimer's disease. The study, presented by associate professor Elisabeth Rothenberg, points to the drink's protective properties with long-term consumption. Caffeine stimulates dopamine production, while antioxidants reduce inflammation, slowing neurodegeneration.

Swedish researchers from Kristianstad University conducted a scientific study establishing that regular coffee consumption may reduce the likelihood of developing Parkinson's disease and Alzheimer's disease. The report, prepared by associate professor Elisabeth Rothenberg and presented at the International Scientific Information Institute on Coffee (ISIC), emphasizes the drink's protective properties with long-term, systematic consumption throughout life. By 2030, the number of Alzheimer's patients is projected to reach 75 million, and by 2050 — 132 million; Parkinson's disease affects about 7 million people annually. The study showed that caffeine stimulates the production of dopamine, which supports cognitive and motor functions, while antioxidants in coffee reduce inflammatory processes that contribute to neurodegeneration. The author of the article is Tali Malkina.